Quizo, Renato R.
HRN: 24-07-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/05/2023
12/11/2023
IV
750mg
Q24
Catheter Associated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes